HKMPY Sygnały na żywo | Maksymalizuj zyski z Getagraph.com

Live Chart Being Loaded With Signals

Commentary (15 bal. 2024 @ 17:33):

Stats
Dzisiejszy wolumen	33.00
Średni wolumen	130.00
Kapitalizacja rynkowa	5.16B
Last Dividend	$0.500 ( 2023-08-11 )
Next Dividend	$0 ( N/A )
P/E	27.35
ATR14	$0 (0.00%)

Hikma Pharmaceuticals PLC Korelacja

10 Najbardziej pozytywne korelacje

10 Najbardziej negatywne korelacje

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Hikma Pharmaceuticals PLC Finanse

Annual	2023
Przychody:	$2.88B
Zysk brutto:	$1.39B (48.35 %)
EPS:	$1.720

FY	2023
Przychody:	$2.88B
Zysk brutto:	$1.39B (48.35 %)
EPS:	$1.720

FY	2022
Przychody:	$2.52B
Zysk brutto:	$1.24B (49.19 %)
EPS:	$1.680

FY	2021
Przychody:	$2.55B
Zysk brutto:	$1.30B (50.96 %)
EPS:	$3.57

Financial Reports:

No articles found.

Hikma Pharmaceuticals PLC Dividends

(Q3/22)	(Q4/22)	(Q1/23)	(Q2/23)	(Q3/23)	(Q4/23)	(Q1/24)	(Q2/24)	(Q3/24)	(Q4/24)
$0.380 (N/A)	$0 (N/A)	$0.740 (N/A)	$0 (N/A)	$0.500 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)

Hikma Pharmaceuticals PLC Dividend Information - Ex Dividend Knight

Dividend Sustainability Score: 10.00 - good (100.00%) | Divividend Growth Potential Score: 4.96 - Stable (0.75%)

Very Unsafe

High risk of being cut

Unsafe

Heightened risk of being cut

Borderline

Moderate risk of being cut

Safe

Unlikely to be cut

Very Safe

Very unlikely to be cut

Information

First Dividend	$0.150	2012-04-18
Last Dividend	$0.500	2023-08-11
Next Dividend	$0	N/A
Payout Date	2023-09-25
Next Payout Date	N/A
# dividends	24	--
Total Paid Out	$8.89	--
Avg. Dividend % Per Year	0.00%	--
Score	3.65	--
Div. Sustainability Score	10.00
Div.Growth Potential Score	4.96
Div. Directional Score	8.04	--

Next Divdend (Est)
(2024-06-21)

$0.505 Estimate 7.56 %

Dividend Stability

0.30 Poor

Dividend Score

3.65

Pay Frequency

Semi-Annually

Yearly Payout

Year	Amount	Yield

Dividend Commentary

The company's strong Dividend Sustainability Score (DSS) indicates its robust capacity to uphold current dividend levels. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. In summary, the company provides a promising overall dividend outlook, balancing both sustainability and growth potential.

Top 10 dividend Companies for OTC

Symbol	Title	Last dividend	Frequency	Yearly Dividend
REMYY	Ex Dividend Junior	2023-09-26	Annually	0.00%
FBAK	Ex Dividend Knight	2023-08-31	Quarterly	0.00%
VONOY	Ex Dividend Junior	2023-05-26	Annually	0.00%
LNNGY	Ex Dividend Knight	2023-08-23	Annually	0.00%
CIHKY	Ex Dividend Knight	2023-07-03	Annually	0.00%
SGAPY	Ex Dividend Knight	2023-08-02	Semi-Annually	0.00%
GLAPY	Ex Dividend Knight	2023-08-25	Semi-Annually	0.00%
AILLM	Ex Dividend Knight	2023-07-14	Quarterly	0.00%
MYBF	Ex Dividend Knight	2023-10-04	Quarterly	0.00%
CODYY	Ex Dividend Knight	2023-06-08	Sporadic	0.00%

Dividend Sustainability Score (DSS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
netProfitMarginTTM	0.0662	1.500	8.68	10.00	[0 - 0.5]
returnOnAssetsTTM	0.0405	1.200	8.65	10.00	[0 - 0.3]
returnOnEquityTTM	0.0864	1.500	-0.151	-0.227	[0.1 - 1]
payoutRatioTTM	0.723	-1.000	2.77	-2.77	[0 - 1]
currentRatioTTM	1.568	0.800	7.16	5.73	[1 - 3]
quickRatioTTM	0.890	0.800	9.47	7.58	[0.8 - 2.5]
cashRatioTTM	0.153	1.500	-0.261	-0.391	[0.2 - 2]
debtRatioTTM	0.254	-1.500	5.76	-8.64	[0 - 0.6]
interestCoverageTTM	5.46	1.000	9.09	9.09	[3 - 30]
operatingCashFlowPerShareTTM	4.79	2.00	8.40	10.00	[0 - 30]
freeCashFlowPerShareTTM	2.96	2.00	8.52	10.00	[0 - 20]
debtEquityRatioTTM	0.542	-1.500	7.83	-10.00	[0 - 2.5]
grossProfitMarginTTM	0.459	1.000	5.69	5.69	[0.2 - 0.8]
operatingProfitMarginTTM	0.165	1.000	8.70	8.70	[0.1 - 0.6]
cashFlowToDebtRatioTTM	0.444	1.000	8.64	8.64	[0.2 - 2]
assetTurnoverTTM	0.612	0.800	9.25	7.40	[0.5 - 2]
Total Score				11.11

Dividend Growth Score (DGS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
peRatioTTM	27.06	1.000	7.37	0	[1 - 100]
returnOnEquityTTM	0.0864	2.50	-0.0971	-0.227	[0.1 - 1.5]
freeCashFlowPerShareTTM	2.96	2.00	9.01	10.00	[0 - 30]
dividendYielPercentageTTM	3.05	1.500	10.00	0	[0 - 0.4]
operatingCashFlowPerShareTTM	4.79	2.00	8.40	10.00	[0 - 30]
payoutRatioTTM	0.723	1.500	2.77	-2.77	[0 - 1]
pegRatioTTM	1.954	1.500	0.306	0	[0.5 - 2]
operatingCashFlowSalesRatioTTM	0.185	1.000	7.88	0	[0.1 - 0.5]
Total Score				4.96

Hikma Pharmaceuticals PLC

Hikma Pharmaceuticals PLC develops, manufactures, markets, and sells a range of generic, branded, and in-licensed pharmaceutical products. The company offers its products in solid, semi-solid, liquid, and injectable final dosage forms. It operates through three segments: Injectables, Generics, and Branded. The Injectables segment provides generic injectable products primarily for use in hospitals. The Generics segment offers oral and other non-injectable generic products for the retail market. The Branded segment offers branded generics and in-licensed products to retail and hospital markets. The company provides its products in various therapeutic areas, including anti-infective, cardiovascular, central nervous system, diabetes, oncology, pain management, and respiratory. It operates in the United Kingdom, the United States, the Middle East, North Africa, Europe, and internationally. The company was founded in 1978 and is based in London, the United Kingdom.